Analysts' Actions: AVB BBBY BBT UNH YUM

NEW YORK (TheStreet) -- CHANGE IN RATINGS:

Alon USA ( ALJ) was downgraded at Goldman Sachs from buy to neutral. Valuation call, as the stock is up more than 33% since late December, Goldman said. $21 price target.

Associated Banc-Corp ( ASBC) was downgraded at Oppenheimer to perform from outperform. Market has recognized turnaround, Oppenheimer said.

Associated Banc-Corp was upgraded at Morgan Stanley to equal-weight. $14 price target. Management is turning the business around, Morgan Stanley said.

AvalonBay Communities ( AVB) was downgraded at Jefferies to hold from buy. $135 price target. 2013 outlook disappointment, Jefferies said.

Armstrong World ( AWI) was upgraded at Barclays from equal-weight to overweight. $64 price target. Company will continue to benefit from a housing shortage, Barclays said.

Bed Bath & Beyond ( BBBY) was upgraded at Citigroup to buy from neutral. $67 price target. Compelling valuation and improving differentiation, Citigroup said.

BB&T ( BBT) was upgraded at Guggenheim from neutral to buy. $38 price target. Company will likely raise its dividend in the near term, Guggenheim said.

Baidu ( BIDU) was downgraded at Stifel Nicolaus from buy to hold. Company is spending more to invest in online video and mobile internet, Stifel said.

Bank of NY Mellon ( BK) was downgraded at Guggenheim from buy to neutral. Valuation call, based on a $28 price target, Guggenheim said.

Cullen/Frost Bankers ( CFR) was upgraded at Oppenheimer to outperform from perform. $68 price target. Loan growth is beginning to accelerate, Oppenheimer said.

CIT Group ( CIT) was downgraded at Nomura from buy to neutral. $45 price target. Valuation call, as the stock is up 16% over the past two months, Nomura said.

Clearwire ( CLWR) was downgraded at DA Davidson from neutral to underperform. DISH deal will likely not go through, DA Davidson said. $2.97 price target.

DR Horton ( DHI) was upgraded at Barclays from equal-weight to overweight. $27 price target. Expect better credit availability to drive demand for entry-level homes, Barclays said.

Bottomline ( EPAY) was downgraded at Craig-Hallum from buy to hold. Valuation call, based on a $29 price target, Craig-Hallum said.

Equity Residential ( EQR) was downgraded at Jefferies to hold from buy. $58 price target. Negative read-through from AVB results, Jefferies said.

Iconix Brand Group ( ICON) was downgraded at Citigroup to neutral from buy. $25 price target. Buffalo acquisition nice, but pricey, Citigroup said.

Invesco ( BBT) was downgraded at BMO Capital from outperform to market perform. Valuation call, based on a $29 price target, BMO said.

Kohl's ( KSS) was downgraded at Citigroup to neutral from buy. $50 price target. Difficult turnaround attempt, Citi said.

Life Technologies ( LIFE) was downgraded at Leerink Swann from outperform to market perform. Taking a cautious view on the next-generation sequencing business, and the stock has made a big run, Leerink Swann said.

Legg Mason ( LM) was downgraded at BMO Capital from market perform to underperform. $26 price target. Company is not positioned well to participate in a reflection toward equities, BMO Capital said.

Macy's ( BBT) was upgraded at Citigroup to buy from neutral. $46 price target. Benficiary of a stronger housing market, Citigroup said.

National Oilwell ( NOV) was downgraded at Bernstein Research from outperform to market perform. $80 price target. Backlog will likely soon peak, Bernstein Research said.

National Oilwell Varco was downgraded at Bernstein to market perform from outperform. $80 price target. Expectations that backlogs will soon peak, Bernstein said.

New York Community Bancorp ( NYCB) was upgraded at Morgan Stanley to overweight. $15 price target. Company restructured its debt, and net interest margin is holding up better than expected, Morgan Stanley said.

PulteGroup ( PHM) was downgraded at Barclays from overweight to equal-weight. $21 price target. New-home prices will likely flatten out, Barclays said.

Realogy ( RLGY) was downgraded at Barclays from overweight to equal-weight. Valuation call, based on a $46 price target, Barclays said.

Sandridge ( SD) was downgraded at J.P. Morgan from overweight to underweight. $5 price target. Company faces a potential financial crunch, J.P. Morgan said.

State Street ( STT) was downgraded at Guggenheim from buy to neutral. $63 price target. Valuation call, as the stock is up 32% since the fall, Guggenheim said.

Constellation Brands ( STZ) was downgraded at Stifel Nicolaus from buy to hold. DOJ suit adds risk to the story.

Stillwater Mining ( SWC) was upgraded at J.P. Morgan from neutral to overweight. $19 price target. Company is leveraged to rising palladium prices, J.P. Morgan said.

Stryker ( SYK) was downgraded at UBS to neutral from buy. Reasonably valued and strong recent move, UBS said.

Target ( TGT) was upgraded at Citigroup to buy from neutral. $72 price target. Well-positioned to gain market share through the new Threshold line, Citi said.

Toll Brothers ( TOL) was downgraded at Barclays to underweight from equal-weight. $36 price target. Expect a shift toward more entry-level home buyers, Barclays said.

Ulta Salon ( ULTA) was initiated with an outperform rating at Credit Suisse. $120 price target. Company has large competitive advantages and can continue to grow, Credit Suisse said.

UnitedHealth ( UNH) was upgraded at Goldman Sachs from neutral to buy. Company was also placed on the Conviction List. Company is an industry leader and leveraged to health care reform, Goldman said. $68 price target.

Williams-Sonoma ( WSM) was initiated with a neutral rating at Credit Suisse. $49 price target. Company has posted inconsistent results, Credit Suisse said.

Yum Brands ( YUM) was downgraded at Robert Baird from outperform to neutral. $72 price target. China outlook remains uncertain and management lowered guidance, Baird said.

Zynga ( ZNGA) was upgraded at Bank of America/Merrill Lynch from underperform to buy. Valuation call, based on a $3.40 price target, BofA/Merrill said.

Quiksilver ( ZQK) was downgraded at B. Riley Caris from buy to neutral. $6.70 price target. Company remains exposed to Europe, B. Riley Caris said.

STOCK COMMENTS / EPS CHANGES

Abbott ( ABT) target raised at Jefferies to $40, Jefferies said. Conservative guidance sets the stage for EPS momentum. Buy rating.

Edwards LifeSciences ( EW) numbers raised at Jefferies. Shares of EW now seen reaching $114, Jefferies said. Estimates also raised on Sapian launch back on track. Buy rating.

Gilead Sciences ( GILD) target lowered at OPPENHEIMER to $45, Oppenheimer said. Reflective of stock split. Outperform rating.

Humana ( HUM) numbers raised at Jefferies. Shares of HUM now seen reaching $93, Jefferies said. Estimates also raised on rising confidence. Buy rating.

Marathon Petroleum ( MPC) target raised at Oppenheimer to $90, Oppenheimer said. Strong outlook boosts valuation. Outperform rating.

Netflix ( NFLX) estimates, target raised at BMO. Shares of NFLX now seen reaching $165, according to BMO Capital. Estimates also increased, given higher subscriber expectations. Market Perform rating.

Yum! Brands ( YUM) numbers lowered at Oppenheimer. Shares of YUM now seen reaching $70. Estimates also lowered on China problems. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz

Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit